[144] Xometry, Inc. SEC Filing

Rhea-AI Filing Summary

Xometry (XMTR) submitted a Form 144 reporting a proposed sale of 80,770 Class A common shares with an aggregate market value of $3,311,570. The sale is to be executed through UBS Financial Services on NASDAQ with an approximate sale date of 08/08/2025. The filing shows the shares were acquired as RSUs on 01/01/2023 (3,729 shares) and 01/01/2024 (7,041 shares), and 70,000 shares arising from a cashless stock option exercise on 08/08/2025. The form reports no securities sold in the past three months and includes the signatory representation that they know of no undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Proposed sale is modest versus the share base; likely limited market impact.

The filing discloses a proposed sale of 80,770 shares with an aggregate market value of $3,311,570. Against the reported 49,339,037 shares outstanding, this represents roughly 0.16% of the share count, indicating the transaction is small in absolute and relative terms. The largest portion (70,000 shares) arises from a cashless option exercise, while the remainder are RSU grants. Given the size and the use of a broker, market disruption is unlikely; this appears to be a routine, disclosed disposition rather than a material corporate event.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 mechanics; documentation reflects standard insider reporting.

The Form 144 identifies the broker as UBS Financial Services and specifies the nature and dates of acquisition: RSUs on 01/01/2023 (3,729) and 01/01/2024 (7,041), plus a cashless option exercise on 08/08/2025 for 70,000 shares. The filer states there have been no sales in the past three months and represents no undisclosed material adverse information. The elements reported are consistent with standard Rule 144 disclosures; there is no indication in the filing of governance or compliance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	80770	3311570	49339037	08/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	01/01/2023	RSU	Issuer			3729	01/01/2023	N/A
Class A Common	01/01/2024	RSU	Issuer			7041	01/01/2024	N/A
Class A Common	08/08/2025	Stock Option Exercise	Issuer			70000	08/08/2025	Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities is XMTR proposing to sell?

80,770 Class A common shares are proposed to be sold, per the Form 144.

What is the aggregate market value and approximate sale date reported?

Aggregate market value is reported as $3,311,570 with an approximate sale date of 08/08/2025.

How were the shares acquired according to the filing?

Shares were acquired as RSUs on 01/01/2023 (3,729) and 01/01/2024 (7,041), and 70,000 from a cashless stock option exercise on 08/08/2025.

Who is the broker named on the Form 144?

The broker listed is UBS Financial Services Inc at the listed Weehawken, NJ address.

Has the filer sold any securities of XMTR in the past three months?

The filing reports Nothing to Report for securities sold during the past three months.

Does the filer make any representation about undisclosed information?

Yes, the filer represents by signing the notice that they do not know of any material adverse information about the issuer that has not been publicly disclosed.